Enlitisa (Shanghai) Pharmaceutical Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 22, 2027.
Recent changes
- 1 of the patents on this record was granted since Aug 24, 2026
- Nov 3 US 12,778,873 Peptides and Their Use in the Treatment of Inflammation
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,059,859 | Anti-Inflammatory Use of Peptide In force · High confidence | In force | High confidence | |
| US 11,672,792 | Topical Formulations Comprising Montelukast and Combinations with Mussel Adhesive Proteins In force · High confidence | In force | High confidence | |
| US 12,129,313 | Anti-Inflammatory Use of Peptide In force · High confidence | In force | High confidence | |
| US 11,680,082 | New Conjugates of Montelukast and Peptides In force · High confidence | In force | High confidence | |
| US 12,612,430 | New Peptides In force · High confidence | In force | High confidence | |
| US 12,778,873 | Peptides and Their Use in the Treatment of Inflammation In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 2 abandoned · 1 no status recorded